New data show that psychiatric advanced practice practitioners provide guideline-concordant schizophrenia care that is ...
In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...
Everyday Health on MSN
Restoring intimacy: Navigating sexual dysfunction in schizophrenia and your treatment options
Sexual dysfunction is a common side effect of antipsychotics, but it doesn’t have to be permanent. Learn about causes, ...
How Does Cobenfy Work, and How Is It Different From Other Medicines Used to Treat Schizophrenia? An imbalance of brain chemicals called neurotransmitters may contribute to schizophrenia. Current ...
The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to a press release. “This drug takes the first new approach to ...
The Food and Drug Administration on Thursday approved Bristol Myers Squibb's highly anticipated schizophrenia drug Cobenfy, the first novel type of treatment for the debilitating, chronic mental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback